We remain steadfast in our mission to harness the pharmaceutical potential of ketamine for a range of mental health, neurological, and pain disorders. - Fabio Chianelli, founder, chairman, and CEO of PharmaTher You can read more about the approval here
Whether the promising preclinical pharmacology will result in successful clinical trials is a question that will be answered in coming years
Patients should be alert for signs of pancreatitis (severe, persistent abdominal pain radiating to the back), gallbladder disease (persistent pain in the right upper abdomen, fever, or jaundice), and dehydration that could lead to acute kidney injury
The 2013 update literature review retrieved an additional RCT
The most common side effects were mild to moderate gastrointestinal issues, such as nausea and diarrhea, which were more frequent with Tirzepatide